1. Home
  2. MNDR vs MBIO Comparison

MNDR vs MBIO Comparison

Compare MNDR & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobile-health Network Solutions Class A Ordinary Shares

MNDR

Mobile-health Network Solutions Class A Ordinary Shares

HOLD

Current Price

$0.69

Market Cap

4.4M

Sector

N/A

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.78

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNDR
MBIO
Founded
2016
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4M
5.1M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
MNDR
MBIO
Price
$0.69
$0.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
155.8K
58.5K
Earning Date
03-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
98.99
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$608,852.40
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.53
52 Week High
$5.42
$7.00

Technical Indicators

Market Signals
Indicator
MNDR
MBIO
Relative Strength Index (RSI) 33.42 62.00
Support Level $0.68 $0.69
Resistance Level $0.97 $0.80
Average True Range (ATR) 0.07 0.08
MACD -0.01 0.01
Stochastic Oscillator 8.94 91.32

Price Performance

Historical Comparison
MNDR
MBIO

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: